Hong Kong Exchange records show that on August 26, Executive Director Wang Yuxiao sold 6,500 shares of Remegen (09995) at an average price of HK$82 per share, totaling HK$533,000.
Following the transaction, Wang's direct shareholding decreased to 22.2921 million shares, representing 10.69% of the company's issued shares, according to the latest disclosure filings.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.